New psychedelics company specializing in psilocybin-based medical research has filed a prospectus.
INVESTOR PROFILE | Ionic Brands
Company:
Ionic Brands
Symbol:
CSE: IONC
Country:
United States
Sector:
Legal Recreational Marijuana
Industry:
Concentrates and Vapes
Established:
2015
Website:
Company:
Ionic Brands
Symbol:
CSE: IONC
Country:
United States
Sector:
Legal Recreational Marijuana
Industry:
Concentrates and Vapes
Established:
2015
Website:
52-Week
Range N/A
Range N/A
Current
Outstanding 108,436,715
Outstanding 108,436,715
Warrants
Options
Fully Diluted
Market Cap.
14,639,000
14,639,000
IONIC BRANDS (CSE: IONC) has a premium portfolio of cannabis concentrate consumer brands. Ionic Brands is one of the top selling concentrate company in Washington State.
Company Brief
Ionic Brands (CSE: IONC) is creating a multi-state, consumer focused, premium cannabis porfolio consisting of iconic national brands.
They have:
- Stylish products
- World Class Management Team
- A proven and repeatable strategy for success
Highlights
Experienced and proven luxury cannabis concentrates brand
One of the tops selling vape brands in WA State with a loyal customer base
Largest standalone oil manufacturer in the state of WA
Consistent sales growth over 3 years with a verified marketing blueprint
Offers investors exposure to a premium luxury cannabis brand
Demonstrated to have a winning formula to become the top vape company in WA
Massive growth opportunity available with expansion into OR, NV and CA
In The News
Ionic Is Changing the Face of Cannabis and Creating a Social Revolution
It’s all in the URL: Ionic.social. “We believe our products are best when enjoyed in a social setting,” said co-founder Christian Struzan.
READ MORE
Marijuana Vaping Is The Most Explosive Growth Play In Marijuana Today
“Nobody smokes marijuana anymore, they vape it.” - New York Times That's not quite true. But it will be soon.
READ MORE
How To Invest In Marijuana Vaping
The marijuana vaporization products (or just "vape") market is set to explode in 2019.
READ MORE
Related Articles
Numinus Positioned To Be Significant Player In Psilocybin R&D
Numinus Wellness Inc. has assembled the licensing and personnel to be a significant player in psilocybin-based drug research.
MindMed Developing IP For Personalized Psychedelic Assisted Therapies
MindMed files patent applications for technologies to screen and optimize dosing of MDMA and LSD.
Oregon mulls banning additives in marijuana vaping products
The Oregon Liquor Control Commission, which regulates marijuana in the state, took its first step toward adopting rules that would ban non-cannabis additives from inhalable products containing THC, though MJ-derived terpenes will be allowed.
Marijuana Stocks Could Soar If Canopy Growth's "Magic Number" for U.S. Cannabis Legalization Is Right
Canopy Growth (NYSE:CGC) CEO David Klein has a "magic number" in mind for when the U.S. will legalize cannabis.
Marijuana Use Is More Moral Than Porn, Gay Relations and Wearing Animal Fur, Americans Say
Americans consider marijuana consumption more morally acceptable than gay relationships, medical testing of animals, the death penalty and abortion, according to a new survey from Gallup.